Trial intelligence / Profile preview

Descriptive Study of Observed Behavioural Awareness and Patients Expectations of Treatment

NCT06050304Recruiting

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Mar 2025
Primary completion
Mar 2026
Countries
1
01

Overview

Open-label, single-arm trial in cocaine use disorder (CUD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Reduction in sleep duration on crack-cocaine use days following a break of at least 2 days compared to crack-cocaine use days without any break. Started Mar 2025; status: recruiting.

02

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on NCT06050304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06050304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call